ONCY – oncolytics biotech inc. - common shares (US:NASDAQ)
Stock Stats
News
Oncolytics Biotech Inc. (NASDAQ: ONCY) was upgraded by analysts at Raymond James to a "moderate buy" rating.
Oncolytics Biotech Inc. (NASDAQ: ONCY) was downgraded by analysts at Leede Financial from a "strong-buy" rating to a "moderate buy" rating.
Oncolytics Biotech Inc. (NASDAQ: ONCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Biotech Companies' Q3 Updates: Promising Cancer Treatments on the Horizon
Biotech Companies' Q3 Updates: Promising Cancer Treatments on the Horizon
Form 6-K ONCOLYTICS BIOTECH INC For: Sep 30
Form 6-K ONCOLYTICS BIOTECH INC For: Nov 12
Form 6-K ONCOLYTICS BIOTECH INC For: Nov 11
Form 6-K ONCOLYTICS BIOTECH INC For: Oct 04
Form 6-K ONCOLYTICS BIOTECH INC For: Sep 19
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.